Oseltamivir News and Research

RSS
Influenza A's resistance to drug Tamiflu increasing

Influenza A's resistance to drug Tamiflu increasing

Oseltamivir-resistant influenza A virus potentially serious to high-risk patients

Oseltamivir-resistant influenza A virus potentially serious to high-risk patients

Scientists identify human monoclonal antibodies effective against bird flu

Scientists identify human monoclonal antibodies effective against bird flu

Influenza vaccine helps 50-64 year olds stay at work

Influenza vaccine helps 50-64 year olds stay at work

Widespread antiviral drug use can accelerate the evolution of drug resistance in viruses

Widespread antiviral drug use can accelerate the evolution of drug resistance in viruses

Bird flu becoming more resistant to antivirals

Bird flu becoming more resistant to antivirals

GlaxoSmithKline ready to supply Biota's Relenza to meet CDC recommendations

GlaxoSmithKline ready to supply Biota's Relenza to meet CDC recommendations

Another bird flu case in Egypt...

Another bird flu case in Egypt...

Roche on Tamiflu label revision

Roche on Tamiflu label revision

Warning of psychiatric side effects with flu drug Tamiflu

Warning of psychiatric side effects with flu drug Tamiflu

Amantadine and rimantadine for influenza A in children and the elderly

Amantadine and rimantadine for influenza A in children and the elderly

Oseltamivir resistance in European Influenza viruses

Oseltamivir resistance in European Influenza viruses

Brits gear up for pandemic while FDA warns about flu jabs side-effects

Brits gear up for pandemic while FDA warns about flu jabs side-effects

Tamiflu significantly reduces illness severity and duration in children one year and older

Tamiflu significantly reduces illness severity and duration in children one year and older

Oseltamivir, the active substance in Tamiflu, unchanged through sewage treatment

Oseltamivir, the active substance in Tamiflu, unchanged through sewage treatment

Roche and WHO reinforce Tamiflu as primary H5N1 treatment

Roche and WHO reinforce Tamiflu as primary H5N1 treatment

Tamiflu for children

Tamiflu for children

Tamiflu could halve the pandemic influenza death toll versus no intervention

Tamiflu could halve the pandemic influenza death toll versus no intervention

Doctor cautions on use of Tamiflu

Doctor cautions on use of Tamiflu

Low frequency of resistance to Tamiflu confirmed

Low frequency of resistance to Tamiflu confirmed